Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raynaud's Treatment Study (RTS)
NCT00000530Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1992
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of nifedipine in Raynaud's disease (4 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Reduction in number of vasospastic attacks. Started Sep 1992; status: completed.
02
Drugs
nifedipine
03
Conditions
Raynaud's disease
Beyond the preview
Go deeper on NCT00000530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000530.